# ACE-031

ACE-031 has 4 registered human trials. It is marketed for 2 different uses.

**In short**

- 4 registered human trials exist for ACE-031.
- ACE-031 is not FDA-approved for any use.
- What has actually been studied: muscle loss, muscular atrophy, duchenne muscular dystrophy.
- Last checked against ClinicalTrials.gov on 2026-07-27.

## What it is sold for

- Muscle growth
- Strength

## What has actually been tested

- Muscle Loss
- Muscular Atrophy
- Duchenne Muscular Dystrophy

## Every trial on record

| Trial ID | Title | Condition | Phase | Status | Enrolled |
|---|---|---|---|---|---|
| [NCT00755638](https://clinicaltrials.gov/study/NCT00755638) | A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 (ActRIIB-IgG1)in Healthy Postmenopausal Volunteers | Muscle Loss | Phase 1 | COMPLETED | 48 |
| [NCT00952887](https://clinicaltrials.gov/study/NCT00952887) | A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 in Healthy Postmenopausal Women | Muscular Atrophy | Phase 1 | COMPLETED | 70 |
| [NCT01239758](https://clinicaltrials.gov/study/NCT01239758) | Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy | Duchenne Muscular Dystrophy | Phase 2 | TERMINATED | 11 |
| [NCT01099761](https://clinicaltrials.gov/study/NCT01099761) | Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy | Duchenne Muscular Dystrophy | Phase 2 | TERMINATED | 24 |

## Common questions

**How many human trials does ACE-031 have?**
4, each listed above with a link to its original record.

**Is ACE-031 FDA approved?**
No. It is not approved by the FDA for any indication.

**Where does this data come from?**
ClinicalTrials.gov. We count interventional human studies only. Every trial
links to its original record.

---

*Automated aggregation from public registries. Not medical advice. No physician
has reviewed this page. Source: https://www.whatsactuallyknown.com/compounds/ace-031*